Conversely, anti-tumor chemokines (e.g., CXCL9, CXCL10, CCL5) mediate protective immunity by recruiting effector lymphocytes (CD8 + T cells, NK cells) while enhancing immune synapse formation and antigen presentation [9, 10]. Here, CD8A is linked to neoplasm.